Allogenica
Develops stem-cell-derived allogeneic T-cell therapies for cancer, rare diseases and autoimmune disorders
Highlights
- Young companyFounded 2022
- New on EvolcAdded 2026-11-10
About Allogenica
Allogenica develops a cell-therapy platform that differentiates stem cells into immature precursor T cells, engineers them and expands them for off-the-shelf treatment candidates. Its approach targets cancer, rare diseases and autoimmune disorders.
The company is based in Lyon, France, and was founded in 2022. Its most advanced drug candidate is expected to enter clinical trials in 2026.
Product: A stem-cell-derived platform for producing engineered allogeneic T-cell therapy candidates.
Jobs at Allogenica
More biotech & pharma companies
Alsinova
Contract research services for pharma, medtech, cosmetics and veterinary sponsors, from preclinical studies to early access programsNew on EvolcAmbiotis
Contract research on inflammation resolution and lipid analytics for pharma, dermo-cosmetic and nutraceutical companiesNew on EvolcAmgen
Biotechnology company developing and manufacturing therapies for serious diseases, operating in FranceNew on EvolcAmpleia
Venture builder creating biotech companies from research teams developing treatments for rare diseasesYoung companyNew on EvolcAnalysis Expertise
Forensic toxicology and genetic testing for courts and law enforcement agenciesYoung companyNew on EvolcAntabio
Clinical-stage biopharma developing antibiotics for multidrug-resistant hospital infections in wards and ICUsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WixHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- ReactMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
- Page markupsoftware structure signature
- Page markupsoftware structure signature
Monitoring
- SentryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.